Introduction
In the human body, the liver is considered important among the largest organs, it takes care of several functions, like the process of metabolism that is essential for life [1] . It is always vulnerable to different toxic molecules of foreign origin due to its location in the human body. These xenobiotic absorbed by the intestine pass first through the liver, which makes it threatened by diseases [2] . Currently, many people suffer from liver diseases induced by several hepatotoxic agents; among these agents are alcohol, infections and chemicals like carbon tetrachloride (CCl 4 ) and paracetamol [3, 4] . Liver affections have become a global problem, and caused every year up to 20 000 deaths arise due to liver affections [5] . Treatment of liver affections with conventional medications may be inadequate Objective: To investigate the hepatoprotective effect of Opuntia dillenii seed oil (ODSO) on CCl 4 provoked liver injury in rat. Methods: Animals were treated orally with ODSO at a concentration of 2 mL/kg, once daily for one week before the first intraperitoneal injection of CCl 4 , and thereafter the administration of the oil was continued for 7 days until the introduction of the second injection of CCl 4 . Fourteen hours after the last dose of CCl 4 , rats were sacrificed, and the relative liver weight, weight gain, alkaline phosphatase, aspartate amino transferase, alanine aminotransferase, direct bilirubin, total bilirubin, triglycerides, total cholesterol, very low density lipoprotein, low density lipoprotein, high density lipoprotein, plasmatic glucose, urea, creatinine, acid uric and malondialdehyde were determined. Results: The significant increase was found in relative liver weight and plasma levels of alanine aminotransferase, aspartate amino transferase, alkaline phosphatase, total bilirubin, direct bilirubin, triglycerides, very low-density lipoprotein, urea, uric acid and malondialdehyde. Likewise, the significant decrease was indicated in the weight gain and the level of glucose plasmatic, and high-density lipoprotein levels in CCl 4 produced liver injury in rats were re-established to normal levels when treated with ODSO. While, no change was observed in the total cholesterol, low-density lipoprotein and creatinine in all animals. Conclusions: We conclude that the ODSO has a protective effect on CCl 4 -mediated liver injury. Hence, we suggest its inclusion as a preventive control of liver disorders. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. or have adverse effects [6] . That is why it is very important to replace chemical drugs with herbal products.
CCl 4 is a toxin among the oldest toxins, and is most used for experimentally induced liver injury in laboratory animals [7] . A hepatotoxic agent that causes liver cell damage is comparable to that of the viral infection. When it enters the liver, CCl 4 is encountered as a xenobiotic, and is converted into two free radicals, which are trichloromethyl and trichloromethyl-peroxyl by the microsomal system dependent on monooxygenase P-450. These two radicals cause lipid peroxidation, which provokes serious liver injury [8] . Antioxidants have been reported to prevent oxidative injury to the liver, and they can prevent the risk of liver disease [9] . This is why we notice that there is a rising interest in natural products that have an antioxidant property, in order to use them to prevent liver pathologies related to oxidative stress [10] .
Opuntia dillenii seed oil (ODSO) is an oil that is marked by a rise degree of unsaturated fatty acids, wherein linoleic acid is the prominent fatty acid, 毬 -sitosterol is the sterol marker while 毭 -tocopherol is the only vitamin E in oil [11] . Antioxidant [12] and anti-inflammatory [13] activities are the only studies that have been done on this oil. The aim of this work is to evaluate the hepatoprotective effect of ODSO on Wistar rat with hepatotoxicity provoked by CCl 4 .
Materials and methods

Chemicals
CCl 4 was purchased from Sigma chemicals, USA. Alanine amino transferase (ALT), aspartate amino transferase (AST), alkaline phosphatase (ALP), total cholesterol, triglycerides, high density lipoprotein (HDL-c), bilirubin direct and total, glucose, total protein, urea, creatinine and acid uric kits were purchased from Biosystems, Spain. All other reagents used in this study were of high quality and analytical grade.
Collection of plant material
The fresh fruits of Opuntia dillenii used in this study were collected in February 2016 from regions in Essaouira, Morocco. The specimen was deposited at Mohammed First University, Oujda, Morocco, under the reference number HUMPOM 351 after its identification by the expert botanist Mohammed Fennan, from the scientific institute of the University Mohammed 桋 .
Preparation of Opuntia dillenii seeds powder
Fruits of Opuntia dillenii were peeled then the seeds were separated from the fruit, cleaned with the distilled water, dried in the oven at 37 曟 for three days and then ground with a blender, until a fine and homogeneous powder was obtained and conserved at -20 曟 until use.
Oil extraction
An amount of 100 g of seed powder was added in 500 mL of petroleum ether, and then the totality was shaken for 24 h under an ambient temperature. After filtration, the organic solvent was removed on a rotary evaporator under temperature at 40 曟 . Moreover, the oil was dried and stored at 4 曟 .
Animals
Twenty-four healthy adult Wistar rats [(200 ± 50) g, 10 weeks old] were employed in this research. Animals were taken from the animal house of the Faculty of Sciences, Mohammed First University, Oujda, Morocco. The rats were grouped in plastic cages in a wellventilated room with soft bedding and accessibility to water and food ad libitum in an environmentally controlled room (22-26 曟 , with a 12/12 h light/dark cycle). The rats were adapted one week preceding treatment.
All rats were cared for in compliance with the internationally accepted Guide for the care and use of laboratory animals, published by the US National Institutes of Health (NIH Publication No. 85-23, Revised in 1985).
Experimental procedure
One week after the adaptation, the rats were arbitrarily grouped into four groups, each including six rats, and treated as follows: The normal control group and CCl 4 control group received distilled water (10 mL/kg). Moreover, the ODSO control group and ODSO + CCl 4 group received ODSO (2 mL/kg). The animals of groups CCl 4 control group, and ODSO+ CCl 4 group received CCl 4 intraperitoneally at a dose 1 mL/kg body weight (25% CCl 4 , solubilized in olive oil; v/v) once a week for two weeks of treatment in order to induce liver injury. Body weights of the rats were measured before and after the treatment. All animals were treated and observed daily for two weeks.
Blood sampling
Twelve hours after the last intraperitoneal injection of CCl 4 , blood samples from these treated rats were drawn from their carotid arteries after being anesthetized under a light ethyl ether. Then the blood was centrifuged at 3 000 rpm for 10 min and at 4 曟 to obtain the plasma, thereafter the plasma was conserved at -20 曟 until analysis. In addition, liver weights were measured and then used for making liver homogenate (10% w / v) in normal saline (pH 7.0) and conserved at -20 曟 for biochemical analyzes.
Serum biochemical parameters determination
ALT and AST were estimated by IFCC method [14] , ALP by paranitrophenyl phosphate method [15] , total cholesterol by enzymatic method [16] , triglycerides by glycerol phosphate oxidase method [17] , HDL-c by the ultra HDL assay, total bilirubin by diazonium saltmethod [18] , direct bilirubin by diazoreaction method [19] , plasma glucose by the oxidase-peroxidase method [20] , urea by Urease-GLDH method [21] , creatinine by kinetic alkaline picrate method [22] , uric acid by uricase-peroxidase method [23] were analyzed following to the reported methods. All analyses were performed in triplicate for every sample on the ARCHITECT c-Systems autoanalyzer (Hamburg, Germany) by using commercial reagent kits.
For low-density lipoprotein (LDL-c), its rate was estimated according to Friedewald et al. [24] . using the following formula: LDL-c = total cholesterol -[HDL-c + very low-density lipoprotein (VLDL-c)]
In addition, VLDL-c was calculated according to the formula of [24] , as follows: VLDL-c = triglycerides/5
Determination of malondialdehyde (MDA)
In this study, hepatic lipid peroxidation was determined by the Buege & Aust method [25] , and this method measures the level of TBARS production as described by Iqbal et al. [26] . After the preparation of the homogenate, 0. 5 mL of the homogenate was added in 0. 5 mL of trichloroacetic acid (30% w/v) and the whole was subject to a centrifugation during 10 min at 3 500 rpm and 4 曟 . Then 1 mL of thiobarbituric acid (0.67% w/v) was added to 1 mL of the supernatant obtained and the whole was placed in a boiling water bath during 10 min. Then to stop the reaction, the mixture was placed in an ice bath. At the end of this reaction, the spectrophotometer was used to measure the mixture of assays at 535 nm, and the calculation was made using the next molar extinction coefficient:
. The results were expressed in nanomoles of MDA produced per gram of tissue.
Statistical analyses
The results were expressed as the mean ± SEM and were subjected to statistical analyses using Graph Pad Prism 5 Software, San Diego, CA, USA. Multiple-group comparisons were analyzed by one-way analysis of variance (ANOVA). P < 0.05 was considered as statistical significant difference.
Results
Effect of ODSO on variation in relative liver weight and body weight gain
The variation in body weight of rats at the end of the experiment was used to assess the growth performance of all the groups studied. The relative weight of the liver and the body weight gain for rats of the groups studied were shown in Table 1 . CCl 4 administration at the end of the first and second week significantly attenuated weight gain and increased the relative weight of the liver in untreated rats (CCl 4 control group) compared to the healthy rats. Moreover, the quotidian treating of hepatotoxic rats by ODSO (ODSO + CCl 4 group) during the two weeks markedly improved growth performance. Indeed, the treatment of hepatotoxic rats (ODSO + CCl 4 group) with ODSO showed a significant reduction in the relative liver weights and an increase in body weight gain compared with the CCl 4 control group rats. Furthermore, the feeding of ODSO alone did not affect the growth performance in healthy rats. 
Effect of ODSO on plasma hepatic markers (AST, ALT and ALP) in hepatotoxic rats.
The intoxication of the liver by CCl 4 was confirmed by measuring the activity of AST, ALT and ALP in the plasma (Figure 1) . The CCl 4 injection of rats induced a significant rise in the activity of ALT, AST and ALP in comparison to the healthy rats. However, the feeding of rats with ODSO at a dose of 2 mL/kg significantly attenuated the elevation of these parameters compared to CCl 4 control group rats. Furthermore, the intake of ODSO alone did not affect the hepatic markers in healthy rats. 
Effect of ODSO on plasma direct and total bilirubin in hepatotoxic rats
The activity of ODSO administration on direct and total bilirubin level in all rats of the groups studied was shown in the Figure 2 . The treatment of rats with CCl 4 induced a significant elevation in plasma bilirubin (direct and total). Moreover, the elevation in bilirubin concentration showed the dysfunction of the excretory function of hepatic cells. This abnormality was significantly corrected after the daily intake of ODSO at a concentration of 2 mL/kg. In addition, the administration of ODSO alone without induced CCl 4 injury did not influence the excretory function of the hepatic cells in the healthy rats. 
Effect of ODSO on plasma total cholesterol, triglycerides and glucose in hepatotoxic rats
In this study, the levels of triglycerides, total cholesterol and glucose were investigated in order to evaluate the effect of ODSO on metabolic function of the liver (Figure 3) . In our study, the intraperitoneal injection of CCl 4 to the rats induced a significant rise in the triglyceride amount, a significant decrease in glucose while the total cholesterol level was not impaired, in comparison with the normal control group rats. However, this alteration in triglyceride and glycemia level was recovered after the intake of ODSO at a concentration of 2 mL/kg. The administration of ODSO alone without CCl 4 -induced injury did not influence the metabolic function of the cells hepatic in the healthy rats.
Effect of ODSO on plasma lipoproteins LDL-c and VLDL-c, HDL-c in hepatotoxic rats
The effect of ODSO on the plasma lipoprotein levels was shown in Figure 4 . The administration of CCl 4 in rats induced a significant elevation in VLDL-c amount, a significant reduction in HDL content and did not affect the LDL-c content in comparison to the healthy rats. However, this change in VLDL-c and HDL-c level was slightly recovered after administration of ODSO at a concentration of 2 mL/kg. The administration of ODSO alone without CCl 4 -induced injury did not influence the lipoprotein levels of the hepatic cells in the healthy rats. The plasma concentration of uric acid, creatinine and urea was examined as biomarkers of renal function ( Figure 5) . The results of our study indicated that the intraperitoneal injection of CCl 4 in rats triggered a significant increase in uric acid, a slight increase of urea and does not affect creatinine level. In addition, the intake of ODSO at a concentration of 2 mL/kg slightly corrected the change of uric acid and urea that was induced by CCl 4 . 
Effect of ODSO on lipid peroxidation in hepatotoxic rats
The impact of ODSO on lipid peroxidation in rats for all groups studied was illustrated in Figure 6 . The intake of CCl 4 provoked a substantial increase in the lipid peroxidation, as indicated by an elevated MDA level, compared to the healthy rats. The daily intake of rats (injected by CCl 4 ) with ODSO during two weeks induced a significant reduction in the content of MDA compared to CCl 4 control group. However, the MDA level in the rats treated only with ODSO was similar to that of the healthy rats. 
Discussion
The liver is considered important among the largest and most complex organs in the body. It is an organ that provides several physiological functions, such as protein synthesis, excretory and secretory function, storage of nutrients and maintenance of homeostasis. It also protects the body against the side effects induced by some drugs and xenobiotic [27] . The usual model used to study the hepatoprotective action of natural products is hepatotoxicity induced by CCl 4 solvent [28] . The latter is a chemical solvent that causes liver damage like to that produced by viral hepatitis [29] . The liver receives CCl 4 as a foreign toxin, and it turns it into two free radicals, which are trichloromethyl and trichloromethyl-peroxyl, by the microsomal system dependent on monooxygenase P-450. Moreover, these two free radicals cause the start of the oxidation of unsaturated lipids [8] and the oxidation of unsaturated lipids is recognized as the main causes of CCl 4 -provoked hepatic affections [30] . In addition, numerous compounds are recognized by their beneficial effects against the liver impairment caused by CCl 4 , by applying their protective action either by the attenuation of CCl 4 -derived free radical production process, or by their antioxidant activities [31] . In our study, the hepatoprotective effect of ODSO against CCl 4 provoked liver injury in healthy adult
Wistar rats was evaluated. Indeed, the hepatoprotective effect of ODSO was evaluated by assessing AST, ALT and ALP activities, as enzyme markers of liver injury [32] . In this work, we also studied On the contrary, the oil did not restore the HDL-c to its normal value. In addition, ODSO ameliorated the renal excretory function by a slight correction of uric acid and urea levels in comparison with rats treated only by CCl 4 . Finally, the oil was found also to improve the growth performance by diminishing relative liver index and raising the body weight gain. The effectiveness of a hepatoprotective drug depends principally on its capacity to maintain standard physiological function or to reduce the damaging impact caused by hepatotoxic agents [34] . Therefore, based on these results obtained from our study, ODSO showed very high hepatoprotective effect in animals with CCL 4 -provoked hepatotoxicity. Regarding the process by which CCL 4 acts in the liver, the generation of free radicals has a crucial role in the hepatotoxic effect [35] . Then, the hepatoprotective activity is related to the antioxidant activity, since it actions of damage are caused by the free radicals [36] . In a study regarding the chemical composition of ODSO, it has been reported that this oil was rich in phenolic compounds. In the same study, 11 phenolic compounds have been identified, namely, catechol, cinnamic acid, phenylpropionic acid, psoralen, syringic acid, sinapaldehyde, 3′-Omethylcatechin, (+)-gallocatechin, bisdemethoxycurcumin, 4′-Omethyl-(-)-epicatechin 3′-O-glucuronide, viscutin 1 [37] . Other reports showed that this oil possesses a considerable antioxidant activity . In that case, the protective effect of this oil against hepatotoxic CCl 4 can be due to its antioxidant effect, by the elimination of the free radicals resulting from the metabolism of CCl 4 in the liver, which are involved in the generation of liver damage. However, more studies on the active compounds of the ODSO and their biochemical mechanisms responsible for the hepatoprotective effect will be necessary.
In conclusion, based on results obtained, ODSO has a significant hepatoprotective effect on rats rendered hepatotoxic by CCl 4 . Moreover, this effect has been represented by the improvement of the state of the enzyme marks related to hepatocellular damage, the metabolic and excretory function of the liver and lipid peroxidation in the liver. Therefore, it may be possible to use this oil as a hepatoprotective agent.
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